The world is on course to witness a staggering rise in cardiovascular disease (CVD), with annual deaths projected to climb from 20.5 million to 35.6 million and total cases nearly doubling to 1.14 billion by 2050, according to a new review article co-authored by scientists at the Aga Khan University.
The research, published in Current Cardiology Reports, highlights a striking paradox: while medical advancements may lower an individual”s risk of dying from heart disease, the overall death toll will continue to escalate, primarily fuelled by rapid global population growth and a progressively aging populace, according to a report today.
‘The world is making real progress in improving cardiovascular care and prevention,” explains Dr Salim S. Virani, senior author of the study and Professor at AKU. ‘But these gains are being outpaced by obesity, diabetes, population growth and aging.’ He added that the progress will continue to be uneven, with high-income countries seeing disproportionate gains compared with low-income nations.
The study identified high blood pressure as the enduring leading cause of cardiovascular mortality worldwide. However, the report projects that high cholesterol, obesity, and diabetes will assume increasingly significant roles, with the latter two forecast to grow at the fastest rates due to dietary changes, urbanisation, and more sedentary lifestyles.
This impending health crisis will not be shared equally across the globe. Low- and middle-income countries are anticipated to experience the steepest rise in CVD, with South Asia, East Asia, and Southeast Asia expected to account for a substantial portion of future fatalities. Many of these regions face a “double burden” of escalating risk factors alongside health systems that are still building capacity to respond.
Despite the alarming projections, the authors emphasised that this future is not predetermined. The report concludes that proven prevention strategies-ranging from healthier diets and tobacco control to early screening and community-based blood pressure programmes-could significantly alter the trajectory of cardiovascular disease.
‘The tools to prevent much of this burden already exist,” Dr Virani stated. ‘The challenge now is implementing these solutions at scale so that prevention reaches people early and equitably across the world.”
The research underscores a critical message for governments and healthcare systems as they plan for the coming decades: confronting cardiovascular risk factors today is essential to shaping the global heart health landscape of tomorrow.